Gem Aromatics Limited, a leading manufacturer of specialty ingredients including essential oils and aroma chemicals, made its much-awaited stock market debut on 26th August 2025. Despite a strong demand during the IPO subscription phase, where the issue was subscribed 13.99 times, the listing on the National Stock Exchange (NSE) was relatively muted, with the shares opening at just 2.5% premium over the issue price. This was in contrast to the expectations created in the grey market, where unlisted shares were trading with a premium of more than 10% ahead of the listing.

The Gem Aromatics IPO was a Book Built Issue worth ₹451.25 crore, consisting of a fresh issue of 0.53 crore shares amounting to ₹175 crore and an offer for sale of 0.85 crore shares worth ₹276.25 crore. The IPO carried a price band of ₹309 to ₹325 per equity share, and the lot size was fixed at 46 shares. For retail investors, the minimum investment was set at ₹14,950, while High-Net-Worth Individuals (HNIs) needed to invest in 14 lots or 644 shares, amounting to ₹2,09,300.

The market capitalisation of Gem Aromatics at the upper price band of ₹325 per share stood at around ₹1,697.70 crore. The company also secured significant participation from anchor investors, raising ₹135.37 crore by allocating 41,65,383 equity shares at ₹325 per share, in consultation with the lead managers. Motilal Oswal Investment Advisors Limited acted as the book running lead manager, while KFin Technologies Limited was the registrar for the issue.

Grey Market Premium (GMP) and Listing Sentiment

In the days leading up to the IPO listing, the Gem Aromatics IPO Grey Market Premium (GMP) was around ₹33, implying an expected listing price of about ₹358 per share. However, as experts often caution, the grey market is an unregulated space where no real trading takes place, and prices are purely based on demand and supply speculation. The actual listing price was far lower than grey market expectations, showing that market sentiment remained cautious despite the oversubscription.

IPO Subscription Status

The Gem Aromatics IPO subscription status reflected strong investor demand across all categories. On the final day of the subscription period, ending 21st August 2025, the IPO was subscribed nearly 14 times in total. This indicated broad-based interest from Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and retail investors.

Company Overview

Established in 1999, Gem Aromatics has built a strong reputation as one of India’s leading manufacturers of essential oils, aroma chemicals, and value-added derivatives. Over two decades, the company has expanded its product portfolio from mint derivatives to clove derivatives, citral-based products, and other synthetic and natural ingredients.

The company caters to industries like oral care, cosmetics, nutraceuticals, pharmaceuticals, personal care, and wellness products. Its expertise lies in mint oil, clove oil, eucalyptus oil, and their derivatives, where it commands leading market positions. For example, in FY 2025, the company held a 65% share in eugenol production and was among the largest processors of DMO and eucalyptus oil in India.

Customers and Exports

Gem Aromatics serves a diverse client base, including well-known brands like Colgate-Palmolive, Dabur India, Patanjali Ayurved, SH Kelkar, Rossari Biotech, Symrise, dōTERRA, and Ventos So Brasil. In FY 2025, the company supplied products to 225 domestic customers and 44 global customers across 18 countries, covering regions such as the Americas, Asia, Africa, and Australia.

The company’s exports are facilitated through its subsidiary in the United States, direct international sales, and third-party agencies. Exports contributed nearly 50% of its revenues, highlighting the company’s global reach.

Manufacturing & R&D

The company operates three state-of-the-art manufacturing facilities located at Budaun (Uttar Pradesh), Silvassa (Dadra and Nagar Haveli and Daman and Diu), and Dahej (Gujarat). Its R&D centre in Maharashtra, staffed by 13 scientists, plays a critical role in product innovation, customization, and sustainability initiatives.

Gem Aromatics has expertise in advanced organic synthesis techniques, including Grignard’s reactions, amide coupling, Friedel-Crafts, cross-coupling, and photochemical reactions. The use of green chemistry and automation has enhanced efficiency, product quality, and environmental sustainability.

Industry Landscape

The listing of Gem Aromatics comes at a time when India’s specialty chemicals industry is witnessing robust growth. Valued at USD 235 billion in 2025, the Indian chemical industry is projected to touch USD 380 billion by 2030, with specialty chemicals growing at 10–12% CAGR.

The global shift towards a China+1 strategy has increased India’s attractiveness as a chemical manufacturing hub. With low operating costs, skilled workforce, and supportive government policies, Indian players like Gem Aromatics are well-positioned to benefit from rising global demand for flavours, fragrances, and essential oils.

Strengths of Gem Aromatics

• Market Leadership in essential oils and derivatives such as mint, clove, and eucalyptus oils.

• Diverse Product Portfolio with over 70 products across four categories.

• Strong Customer Relationships with leading FMCG and personal care companies globally.

• Strategically Located Manufacturing Facilities with scalability potential.

• Experienced Leadership Team, including award-winning entrepreneurs driving expansion.

Risks and Concerns

Despite its strengths, investors must consider the business risks:

• High customer concentration, with significant dependence on dōTERRA Global Limited.

• Heavy reliance on mint derivatives, which contribute nearly 70% of revenue.

• Pending litigation over land ownership of its Budaun facility.

• Dependence on imported raw materials like crude clove oil, exposing the company to cost volatility.

• Significant exposure to international markets, making revenues vulnerable to global economic and regulatory changes.

Use of IPO Proceeds

The company plans to utilise the net proceeds from the IPO for:

1. Prepayment or repayment of borrowings amounting to ₹1,400 million for both the company and its subsidiary Krystal Ingredients Pvt Ltd.

2. General corporate purposes, including expansion and strengthening of operations.

Market Debut in Context

While the listing premium was muted at 2.5%, analysts believe that the long-term prospects of Gem Aromatics remain strong due to its leading market position, diversified portfolio, and strong export demand. The muted listing performance could reflect short-term market sentiment, but the company’s fundamentals suggest potential for steady growth.

The Upcoming IPOs in this week and coming weeks are Amanta Healthcare, Rachit Paints, Abril Paper Tech, Sneha Organics, Sugs Lloyd, Anlon Healthcare, NIS Management, Sattva Engineering Construction, Globtier Infotech, Current Infraprojects, Vikran Engineering.

The Current active IPO are Shivashrit Foods, Anondita Medicare, Classic Electrodes (India), ARC Insulation & Insulators.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.